-
Understanding Disparities in Melanoma DiagnosisBlack men with melanoma are more likely than other populations to die of the disease. Here’s why, and what to look for.
by Kyle Bagenstose
-
August 11: The Week in Cancer NewsResearch links testicular cancer in military firefighters to ‘forever chemicals,’ and older women who are screened for breast cancer at risk for overdiagnosis.
by Marci A. Landsmann
-
Patient VoicesRead stories about cancer and treatment from the people who are living through it.
-
August 4: The Week in Cancer NewsGenetic testing can help establish inherited cancer risk, and a new cancer registry tracks breast and prostate cancer in people of African origin.
by Kevin McLaughlin
-
July 28: The Week in Cancer NewsLess than four minutes of physical activity per day linked to lower cancer risk, and vaccination helped improve outcomes for cancer patients with COVID-19.
by Thomas Celona
-
July 21: The Week in Cancer NewsASCO guideline emphasizes the importance of assessment for older cancer patients, and a change in mammogram recommendations reignites screening debates.
by Eric Fitzsimmons
-
July 14: The Week in Cancer NewsBlack men with melanoma have higher risk of dying, and CAR T-cell therapy provides hope for aggressive lymphoma.
by Marci A. Landsmann
-
After Colorectal Cancer, Survivors Face Higher Risk for a Second CancerResearchers find increased risk of four types of secondary cancer in patients diagnosed with early-onset colorectal cancer.
by Sandra Gordon
-
July 7: The Week in Cancer NewsReducing cancer treatment to improve quality of life without lowering effectiveness, and death rates are climbing for certain cancers in Hispanic Americans.
by Kevin McLaughlin
-
Susan Love, Breast Surgeon and Patient Advocate, Dies at 75Love co-wrote Dr. Susan Love’s Breast Book and was vocal in promoting improved breast cancer diagnosis and treatment.
by Kevin McLaughlin
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
